Literature DB >> 25356107

Response gene to complement 32 (RGC-32) in endothelial cells is induced by glucose and helpful to maintain glucose homeostasis.

Shuzhen Guo1, Melissa J Philbrick2, Xiaojing An2, Ming Xu2, Jiaping Wu2.   

Abstract

Endothelium dysfunction has been understood primarily in terms of abnormal vasomotor function, which plays an important role in the pathogenesis of diabetes and chronic diabetic complications. However, it has not been fully studied that the endothelium may regulate metabolism itself. The response gene to complement 32 (RGC-32) has be considered as an angiogenic inhibitor in the context of endothelial cells. We found that RGC-32 was induced by high fat diet in vivo and by glucose or insulin in endothelial cells, and then we set out to investigate the role of endothelial RGC-32 in metabolism. DNA array analysis and qPCR results showed that glutamine-fructose-6-phosphate aminotransferase [isomerizing] 1 (GFPT1), solute carrier family 2 (facilitated glucose transporter), member 12 (SLC2A12, GLUT12) and glucagon-like peptide 2 receptor (GLP2R) may be among possible glucose metabolism related downstream genes of RGC-32. Additionally, in the mice with endothelial specific over-expressed RGC-32, the disposal of carbohydrate was improved without changing insulin sensitivity when mice were faced with high fat diet challenges. Taken together, our findings suggest that RGC-32 in the endothelial cells regulates glucose metabolism related genes and subsequent helps to maintain the homeostasis of blood glucose.

Entities:  

Keywords:  The response gene to complement 32; endothelial cells; glucose homeostasis

Year:  2014        PMID: 25356107      PMCID: PMC4211757     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  Biochemistry and molecular cell biology of diabetic complications.

Authors:  M Brownlee
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

Review 2.  Endothelial dysfunction - a major mediator of diabetic vascular disease.

Authors:  Cristina M Sena; Ana M Pereira; Raquel Seiça
Journal:  Biochim Biophys Acta       Date:  2013-08-29

3.  The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.

Authors:  J de Heer; J Pedersen; C Orskov; J J Holst
Journal:  Diabetologia       Date:  2007-08-04       Impact factor: 10.122

4.  Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance.

Authors:  L F Hebert; M C Daniels; J Zhou; E D Crook; R L Turner; S T Simmons; J L Neidigh; J S Zhu; A D Baron; D A McClain
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

5.  RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium.

Authors:  Angela F Messmer-Blust; Melissa J Philbrick; Shuzhen Guo; Jiaping Wu; Ping He; Shaodong Guo; Jian Li
Journal:  Circ Res       Date:  2012-07-25       Impact factor: 17.367

6.  Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.

Authors:  H O Steinberg; H Chaker; R Leaming; A Johnson; G Brechtel; A D Baron
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

7.  Epigenetic modifications induced by RGC-32 in colon cancer.

Authors:  Sonia I Vlaicu; Cosmin A Tegla; Cornelia D Cudrici; Matthew Fosbrink; Vingh Nguyen; Philippe Azimzadeh; Violeta Rus; Hegang Chen; Petru A Mircea; Abulkalam Shamsuddin; Horea Rus
Journal:  Exp Mol Pathol       Date:  2009-10-31       Impact factor: 3.362

8.  Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.

Authors:  James B Meigs; Frank B Hu; Nader Rifai; JoAnn E Manson
Journal:  JAMA       Date:  2004-04-28       Impact factor: 56.272

9.  PPARgamma in the endothelium regulates metabolic responses to high-fat diet in mice.

Authors:  Takeshi Kanda; Jonathan D Brown; Gabriela Orasanu; Silke Vogel; Frank J Gonzalez; Juliano Sartoretto; Thomas Michel; Jorge Plutzky
Journal:  J Clin Invest       Date:  2008-12-08       Impact factor: 14.808

10.  Improved insulin sensitivity by GLUT12 overexpression in mice.

Authors:  Scott H Purcell; Lauren B Aerni-Flessner; Alexandra R Willcockson; Kelly A Diggs-Andrews; Simon J Fisher; Kelle H Moley
Journal:  Diabetes       Date:  2011-03-25       Impact factor: 9.461

View more
  7 in total

Review 1.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

2.  New insights into the roles of RGC-32.

Authors:  Qingjie Wang; Xun Qu
Journal:  Cell Mol Immunol       Date:  2018-03-05       Impact factor: 11.530

3.  RGC-32 Deficiency Protects against Hepatic Steatosis by Reducing Lipogenesis.

Authors:  Xiao-Bing Cui; Jun-Na Luan; Shi-You Chen
Journal:  J Biol Chem       Date:  2015-07-01       Impact factor: 5.157

4.  Nox2 contributes to hyperinsulinemia-induced redox imbalance and impaired vascular function.

Authors:  Abeer M Mahmoud; Mohamed M Ali; Edwin R Miranda; Jacob T Mey; Brian K Blackburn; Jacob M Haus; Shane A Phillips
Journal:  Redox Biol       Date:  2017-06-03       Impact factor: 11.799

5.  Pumilio directs deadenylation-associated translational repression of the cyclin-dependent kinase 1 activator RGC-32.

Authors:  Michèle Brocard; Sarika Khasnis; C David Wood; Claire Shannon-Lowe; Michelle J West
Journal:  Nucleic Acids Res       Date:  2018-04-20       Impact factor: 16.971

6.  Loss of Response Gene to Complement 32 (RGC-32) in Diabetic Mouse Retina Is Involved in Retinopathy Development.

Authors:  Wen-Ling Liao; Jane-Ming Lin; Shih-Ping Liu; Shih-Yin Chen; Hui-Ju Lin; Yeh-Han Wang; Yu-Jie Lei; Yu-Chuen Huang; Fuu-Jen Tsai
Journal:  Int J Mol Sci       Date:  2018-11-17       Impact factor: 5.923

Review 7.  Response Gene to Complement 32 in Vascular Diseases.

Authors:  Xiao-Bing Cui; Shi-You Chen
Journal:  Front Cardiovasc Med       Date:  2018-09-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.